Teladoc Health, Inc. (NYSE:TDOC) Receives Average Rating of "Hold" from Brokerages

Key Points

• Analysts maintain a “Hold” consensus on Teladoc Health, with 10 hold, five buy, and one sell rating among 16 brokerages. The average 1-year price target is $7.54.
• Teladoc shares opened at $6.20, with a $1.13 billion market capitalization, after trading between $4.40 and $9.89 over the past year. The company reported a quarterly loss of $0.21 per share, better than estimates, but revenue of $606.9 million declined 4% year over year and missed expectations.
• Insiders sold shares primarily to cover tax obligations from vested equity awards, while institutional investors own approximately 76.82% of the company.

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) has received a consensus recommendation of "Hold" from the sixteen brokerages that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, ten have assigned a hold recommendation and five have given a buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $7.5357.

A number of research analysts recently commented on the company. Citigroup lowered their price objective on Teladoc Health from $11.00 to $7.50 and set a "neutral" rating for the company in a research note on Monday, August 3rd. Weiss Ratings reiterated a "sell (d-)" rating on shares of Teladoc Health in a research note on Wednesday, August 19th. Bank of America boosted their price target on shares of Teladoc Health from $9.00 to $10.50 and gave the company a "buy" rating in a report on Tuesday, July 7th. Finally, Canaccord Genuity Group lowered their price target on shares of Teladoc Health from $11.00 to $10.00 and set a "buy" rating for the company in a research report on Thursday, July 30th.

Teladoc Health Stock Down 3.1%

Shares of NYSE TDOC opened at $6.20 on Tuesday. The firm's 50-day moving average price is $8.06 and its two-hundred day moving average price is $6.61. Teladoc Health has a 52-week low of $4.40 and a 52-week high of $9.89. The stock has a market capitalization of $1.13 billion, a P/E ratio of -6.26 and a beta of 2.12.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its earnings results on Wednesday, July 29th. The health services provider reported ($0.21) EPS for the quarter, beating the consensus estimate of ($0.25) by $0.04. The company had revenue of $606.93 million during the quarter, compared to analyst estimates of $615.44 million. Teladoc Health had a negative return on equity of 12.15% and a negative net margin of 7.13%.The business's revenue was down 4.0% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.19) earnings per share. Teladoc Health has set its Q3 2026 guidance at -0.300--0.200 EPS and its FY 2026 guidance at -1.000--0.750 EPS. As a group, equities research analysts expect that Teladoc Health will post -0.89 earnings per share for the current year.

Insider Activity

In other Teladoc Health news, insider Fernando M. Rodrigues sold 5,677 shares of the business's stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total transaction of $43,315.51. Following the completion of the transaction, the insider directly owned 9,572 shares of the company's stock, valued at $73,034.36. The trade was a 37.23% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Adam C. Vandervoort sold 7,906 shares of the company's stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total transaction of $60,322.78. Following the completion of the transaction, the insider owned 110,261 shares of the company's stock, valued at approximately $841,291.43. This trade represents a 6.69% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 39,195 shares of company stock valued at $299,058. Company insiders own 0.70% of the company's stock.

Institutional Trading of Teladoc Health

Large investors have recently added to or reduced their stakes in the business. Creative Planning boosted its position in Teladoc Health by 7.7% during the 3rd quarter. Creative Planning now owns 20,567 shares of the health services provider's stock worth $159,000 after acquiring an additional 1,462 shares during the period. Versant Capital Management Inc grew its stake in shares of Teladoc Health by 33.3% in the second quarter. Versant Capital Management Inc now owns 8,207 shares of the health services provider's stock worth $70,000 after purchasing an additional 2,052 shares in the last quarter. Syon Capital LLC increased its holdings in shares of Teladoc Health by 19.1% during the fourth quarter. Syon Capital LLC now owns 14,140 shares of the health services provider's stock valued at $99,000 after purchasing an additional 2,264 shares during the period. ProShare Advisors LLC raised its stake in shares of Teladoc Health by 8.2% during the fourth quarter. ProShare Advisors LLC now owns 32,532 shares of the health services provider's stock valued at $228,000 after purchasing an additional 2,457 shares in the last quarter. Finally, PNC Financial Services Group Inc. raised its stake in shares of Teladoc Health by 177.7% during the fourth quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider's stock valued at $31,000 after purchasing an additional 2,810 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc's service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source